Cantor Fitzgerald Strengthens Healthcare and Biotech Research Team with Notable Additions
Cantor Fitzgerald Amplifies Its Healthcare and Biotech Research Team with High-Profile Additions In a recent move that has caught the attention of the investment banking world, Cantor Fitzgerald has made significant additions to its Healthcare and Biotechnology Equity Research Team. The firm has welcomed Josh Schimmer, M.D., and Eric Schmidt, Ph.D., two highly respected figures …